We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+5.55%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$572B
AUM Growth
+$35.4B
Cap. Flow
-$1.41B
Cap. Flow %
-0.25%
Top 10 Hldgs %
24.8%
Holding
13,475
New
1,572
Increased
5,247
Reduced
4,924
Closed
1,625

Sector Composition

Rank Sector Weight
1 Miscellaneous 93.75%
2 Technology 1.85%
3 Consumer Discretionary 1.02%
4 Financials 0.76%
5 Communication Services 0.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FOXO
11576
DELISTED
FOXO TECHNOLOGIES INC A
FOXO
$19.8K ﹤0.01%
+5,223
New +$20.3K
VSEE
11577
DELISTED
VSEE HEALTH INC
VSEE
$19.6K ﹤0.01%
+13,154
New +$42.1K
DWSN icon
11578
Dawson Geophysical
DWSN
$101M
$19.3K ﹤0.01%
+12,236
New +$21K
GROV icon
11579
Grove Collaborative
GROV
$42.5M
$19.3K ﹤0.01%
14,264
+2,347
+20% +$3.35K
BOF icon
11580
BranchOut Food
BOF
$63.4M
$19.1K ﹤0.01%
+11,955
New +$15.4K
AEI icon
11581
Alset
AEI
$57.2M
$19.1K ﹤0.01%
14,825
+226
+2% +$262
TGL icon
11582
Treasure Global
TGL
$4.93M
$19.1K ﹤0.01%
+15
New +$19.7K
XFOR icon
11583
PUT
X4 Pharmaceuticals
XFOR
$419M
$19K ﹤0.01%
947
-606
-39% -$12.6K
IFRX icon
11584
InflaRx
IFRX
$335M
$18.9K ﹤0.01%
+12,374
New +$18.8K
ALXO icon
11585
PUT
ALX Oncology
ALXO
$283M
$18.9K ﹤0.01%
10,400
-94,600
-90% -$352K
GAN
11586
DELISTED
GAN Ltd
GAN
$18.9K ﹤0.01%
+10,683
New +$17.6K
MVST icon
11587
CALL
Microvast
MVST
$296M
$18.8K ﹤0.01%
75,200
-9,800
-12% -$3.27K
ATHE
11588
Alterity Therapeutics
ATHE
$82.7M
$18.7K ﹤0.01%
13,932
-9,379
-40% -$13.8K
OM icon
11589
Outset Medical
OM
$76.9M
$18.6K ﹤0.01%
1,832
-17,405
-90% -$518K
FBIO icon
11590
PUT
Fortress Biotech
FBIO
$93.4M
$18.6K ﹤0.01%
12,800
-12,200
-49% -$23.2K
ZENV
11591
DELISTED
Zenvia
ZENV
$18.4K ﹤0.01%
+11,929
New +$21.6K
FLZH
11592
FLASH SPORTS & MEDIA HLDG
FLZH
$5.45M
$18.4K ﹤0.01%
532
-495
-48% -$17.3K
JOB icon
11593
GEE Group
JOB
$27.9M
$18.3K ﹤0.01%
70,310
+52,664
+298% +$14.9K
CLSD
11594
PUT
DELISTED
Clearside Biomedical
CLSD
$18.3K ﹤0.01%
+960
New +$16.4K
SCWO icon
11595
374Water
SCWO
$47.5M
$18.3K ﹤0.01%
+1,343
New +$16.3K
NRGV icon
11596
CALL
Energy Vault
NRGV
$682M
$18.2K ﹤0.01%
19,000
-5,200
-21% -$5.23K
AGMH icon
11597
AGM Group Holdings
AGMH
$4.58M
$18.2K ﹤0.01%
212
-73
-26% -$3.61K
UONE icon
11598
CALL
Urban One Class A
UONE
$22.2M
$18.1K ﹤0.01%
1,030
-50
-5% -$994
PRPL icon
11599
CALL
Purple Innovation
PRPL
$19.6M
$18.1K ﹤0.01%
732
-1,760
-71% -$50.8K
GANX icon
11600
CALL
Gain Therapeutics
GANX
$80.7M
$17.8K ﹤0.01%
+10,000
New +$12.6K

Similar funds

Jeff Yass's Q3 2024 Portfolio in Review

As of Q3 2024, Jeff Yass held 13,475 positions worth $572B, up 6.6% from $537B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Jeff Yass's Q3 2024 filing shows 1,572 new, 5,247 increased, 4,924 reduced and 1,625 closed positions. Its largest new stake was Camtek: 408,771 shares worth $32.6M. The largest sale was Apple, an estimated $845M.

By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q3 2024 buy was Camtek: 408,771 shares worth $32.6M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.58B increase.
  • Jeff Yass's biggest Q3 2024 reduction was Apple, cutting an estimated $845M.
  • Jeff Yass fully exited iShares Convertible Bond ETF in Q3 2024, selling an estimated $80.5M.
  • Jeff Yass's ten largest holdings make up 25% of its $572B portfolio in Q3 2024.
  • Jeff Yass opened 1,572 new positions and closed 1,625 in Q3 2024.
  • Jeff Yass's portfolio value rose 6.6% quarter-over-quarter to $572B.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.